Skip to content

Management of clinical research network for Amyloidosis and Prognostic factor analysis

Management of clinical research network for Amyloidosis and Prognostic factor analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005075
Enrollment
120
Registered
2020-06-02
Start date
2019-02-14
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sungkyunkwan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Subject patient: AL amyloidosis patient. Specific criteria for selection are as follows. 1) If the heart is organically identified with amyloid deposits, positive in the special dye of Congo red,AmyloidP, or abnormal accumulation of fibrous proteins in electron microscopy is found. 2) Patients whose amyloidosis is confirmed in other tissues and whose cardiac amyloidosis is appropriate for cardiogram or cardiac magnetic resonance tests. ? Heart ultrasonography suitable for heart amyloidosis: Average left ventricular wall thickness >12mm and without valve disease or other cardiovascular disease such as hypertension ? Appropriate cardiac magnetic resonance test for cardiac amyloidosis: In the event of a wide range of endocardium retarded intensification or proper nulling of the heart muscle is not possible during delayed enhancement filming 3) Patients identified as aTTR amyloidosis 4) Patients who have agreed to participate in research in writing

Exclusion criteria

Exclusion criteria: 1) Heart amyloidosis is suspected from an ultrasound or a cardiac magnetic resonance examination, but pathologically amyloidosis is not confirmed by a biopsy of more than one organ, including abdominal fat tissue. 2) Those who do not agree to participate in this study and genetic/biochemical tests

Design outcomes

Primary

MeasureTime frame
Mortality at anytime

Secondary

MeasureTime frame
Treatment response

Countries

Korea, Republic of

Contacts

Public ContactEunseok Jeon

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026